600196 复星医药
2025/03 -
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资25,018,3251.32%24,691,50123,919,39923,144,77122,683,713
投资性房地产0--0000
固定资产17,447,7030.36%17,385,19515,129,37110,267,8598,919,058
在建工程3,555,1133.48%3,435,4514,938,2814,896,6973,617,705
无形资产14,371,961-0.67%14,468,39313,482,01612,471,05710,276,254
商誉10,888,058-0.16%10,905,08310,851,99910,337,0539,399,987
其他非流动资产12,270,7191.55%12,083,88411,355,96910,767,2927,972,697
83,551,8790.70%82,969,50779,677,03671,884,72962,869,415

流动资产
货币资金13,715,9631.42%13,523,93313,693,59116,241,31310,317,224
应收账款7,857,350-1.19%7,952,0737,643,7367,588,0996,029,720
存货6,823,050-6.00%7,258,6497,537,7686,882,4325,472,547
其他流动资产6,042,2474.97%5,756,4064,917,4744,567,3338,617,416
34,438,610-0.15%34,491,06133,792,56935,279,17830,436,907

流动负债
短期借款17,874,459-4.47%18,711,31514,728,45411,931,5379,420,129
应付票据568,967-8.09%619,015652,252857,879548,388
应付帐款4,869,859-9.45%5,378,3705,507,3665,426,1624,515,305
其他流动负债12,187,252-4.37%12,743,96912,869,51115,082,49114,834,650
35,500,537-5.21%37,452,66933,757,58433,298,06929,318,473
流动资产净值(1,061,927)-64.14%(2,961,609)34,9851,981,1091,118,435
资产总额减流动负债82,489,9523.10%80,007,89879,712,02173,865,83863,987,849

非流动负债
长期借款11,560,44313.30%10,203,50013,504,92311,600,4376,694,183
应付债券0-100.00%240,0000499,4312,354,886
其他非流动负债10,079,6074.66%9,630,6699,590,8387,657,0606,559,212
21,640,0507.80%20,074,16923,095,76119,756,92815,608,281

总权益
    实收股本2,671,3260.00%2,671,3262,672,3992,672,1572,562,899
    储备项目45,252,3051.49%44,589,78043,012,36341,910,30136,632,660
股东权益47,923,6321.40%47,261,10745,684,76244,582,45839,195,558
非控股权益12,926,2702.00%12,672,62210,931,4999,526,4529,184,010